Send Inquiry

Request To Call Back

Esomeprazole Magnesium Pellets

Get a Price/Quote

MOQ : 50 Kilograms

Esomeprazole Magnesium Pellets Specification

Product Type
Active Pharmaceutical Ingredient (API)

Solubility
Practically insoluble in water, freely soluble in methanol and ethanol

Application
Used in the formulation of delayed release tablets/capsules for acid-related disorders

Smell
Odorless

Purity
99%

Ph Level
Between 9.5 - 10.5

Molecular Weight
369.72 g/mol

Storage
Store in a cool, dry place, protected from light and moisture

Properties
Gastro-resistant, stable under pharmaceutical processing conditions

Grade
Pharmaceutical Grade

Molecular Formula
C17H19MgN3O3S

Physical Form
Pellets

Appearance
White to off-white pellets

CAS No
119141-88-7

Ingredients
Esomeprazole Magnesium

Melting Point
155C-158C

Usage
Treats gastroesophageal reflux disease (GERD) and peptic ulcer

Taste
Bland

Poisonous
Non-poisonous

Shelf Life
36 months

HS Code
2933 59 90

Shape
Spherical

Structural Formula
Available on request

Esomeprazole Magnesium Pellets Trade Information

Minimum Order Quantity
50 Kilograms

Supply Ability
1 Kilograms Per Week

Delivery Time
1 Week

About Esomeprazole Magnesium Pellets

Esomeprazole Magnesium Pellets

Other Name : magnesium; 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide; 5-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide
CAS Number : 161973-10-0
Molecular Formula : 2(C17H18N3O3S)2.Mg
Application : Antiulcerative

Superior Gastro-Resistant Pellets

These esomeprazole magnesium pellets feature robust enteric coating, rendering them gastro-resistant and stable under pharmaceutical processing conditions. Tailored for delayed-release oral formulations, they ensure effective, targeted delivery to the intestine. Their spherical shape and particle size between 200 and 800 microns facilitate superior blending and handling during tablet or capsule manufacturing.

Quality and Compliance Assured

Manufactured in strict accordance with pharmacopoeial guidelines (IP/USP/EP), each batch undergoes rigorous quality control tests for purity, heavy metal content, microbial limits, and physical characteristics. Pellets are supplied in pharmaceutical grade purity (99%) and are stable for up to 36 months under recommended storage conditions.

FAQs of Esomeprazole Magnesium Pellets:

Q: How should Esomeprazole Magnesium Pellets be stored and transported?

A: These pellets must be stored in a cool, dry place, protected from light and moisture. Transport should be in tightly sealed HDPE drums, lined with double polyethylene bags, to maintain stability and prevent contamination.

Q: What is the manufacturing process for these pellets?

A: Esomeprazole Magnesium Pellets are produced using a non-pelletizing process followed by enteric coating. This unique method ensures the pellets are gastro-resistant and suitable for delayed-release pharmaceutical formulations.

Q: When and where are these pellets typically used?

A: These pellets are used during the formulation stage for manufacturing delayed-release tablets and capsules. They are widely utilized by pharmaceutical companies, distributors, and manufacturers dealing with acid-related disorders.

Q: What is the application and therapeutic benefit of these pellets?

A: The pellets are formulated into oral dosage forms to treat acid-related conditions such as GERD and peptic ulcers. Their gastro-resistant property allows the drug to bypass the stomach and release in the intestine, enhancing therapeutic efficacy.

Q: How do the quality control standards ensure product safety?

A: Each batch complies with pharmacopoeial standards (IP/USP/EP), including limits for heavy metals (10 ppm), microbial presence, and high purity (99%). Strict adherence to these standards ensures safe and effective pharmaceutical ingredients.

Q: Why is the particle size and bulk density important in these pellets?

A: Particle size (200800 microns) and bulk density (0.450.75 g/ml) are critical for uniform blending during tablet or capsule production, achieving consistent dosage forms, and ensuring reliable performance in final pharmaceutical products.

Tell us about your requirement